Risk Factors Update Summary
- Net losses increased from $10,245,922 in 2022 to $11,099,488 in 2023.
- Accumulated deficit rose from $59,265,364 in 2022 to $59,324,812 in 2023.
- Identified a material weakness in internal control over financial reporting.
- Technology expenses increased from $4,386,206 in 2022 to $5,449,165 in 2023.
- Federal net operating loss carryforwards rose from $40.8 million to $50.8 million.
- Revenue derived from specimens increased from 52% in 2022 to 56% in 2023.
- Received a deficiency notice from Nasdaq due to non-compliance with the minimum bid price.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1558569&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.